172 related articles for article (PubMed ID: 34600546)
21. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
[TBL] [Abstract][Full Text] [Related]
22. Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma.
Kim SY; Kim SM; Lim S; Lee JY; Choi SJ; Yang SD; Yun MR; Kim CG; Gu SR; Park C; Park AY; Lim SM; Heo SG; Kim H; Cho BC
Clin Cancer Res; 2021 Aug; 27(15):4397-4409. PubMed ID: 34083237
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening.
Luo Z; Wang B; Luo F; Guo Y; Jiang N; Wei J; Wang X; Tseng Y; Chen J; Zhao B; Liu J
BMC Med; 2023 Sep; 21(1):336. PubMed ID: 37667332
[TBL] [Abstract][Full Text] [Related]
24. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer.
He X; Jiang Y; Zhang L; Li Y; Hu X; Hua G; Cai S; Mo S; Peng J
Front Bioeng Biotechnol; 2023; 11():1190637. PubMed ID: 37284236
[No Abstract] [Full Text] [Related]
25. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
Demyan L; Habowski AN; Plenker D; King DA; Standring OJ; Tsang C; St Surin L; Rishi A; Crawford JM; Boyd J; Pasha SA; Patel H; Galluzzo Z; Metz C; Gregersen PK; Fox S; Valente C; Abadali S; Matadial-Ragoo S; DePeralta DK; Deutsch GB; Herman JM; Talamini MA; Tuveson DA; Weiss MJ
Ann Surg; 2022 Sep; 276(3):450-462. PubMed ID: 35972511
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer.
Maru Y; Kohno M; Suzuka K; Odaka A; Masuda M; Araki A; Itami M; Tanaka N; Hippo Y
Hum Cell; 2024 May; 37(3):840-853. PubMed ID: 38546950
[TBL] [Abstract][Full Text] [Related]
27. "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction".
Papaccio F; García-Mico B; Gimeno-Valiente F; Cabeza-Segura M; Gambardella V; Gutiérrez-Bravo MF; Alfaro-Cervelló C; Martinez-Ciarpaglini C; Rentero-Garrido P; Zúñiga-Trejos S; Carbonell-Asins JA; Fleitas T; Roselló S; Huerta M; Sánchez Del Pino MM; Sabater L; Roda D; Tarazona N; Cervantes A; Castillo J
J Exp Clin Cancer Res; 2023 Jan; 42(1):8. PubMed ID: 36604765
[TBL] [Abstract][Full Text] [Related]
28. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
Schmäche T; Fohgrub J; Klimova A; Laaber K; Drukewitz S; Merboth F; Hennig A; Seidlitz T; Herbst F; Baenke F; Ada AM; Groß T; Wenzel C; Ball CR; Praetorius C; Schmidt T; Ringelband-Schilling B; Koschny R; Stenzinger A; Roeder I; Jaeger D; Zeissig S; Welsch T; Aust D; Glimm H; Folprecht G; Weitz J; Haag GM; Stange DE
Mol Cancer; 2024 Jan; 23(1):10. PubMed ID: 38200602
[TBL] [Abstract][Full Text] [Related]
29. Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid.
Wang Z; Jin Y; Guo Y; Tan Z; Zhang X; Ye D; Yu Y; Peng S; Zheng L; Li J
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803322
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of parathyroid organoids.
Sekhar KR; Codreanu SG; Williams OC; Rathmell JC; Rathmell WK; McLean JA; Sherrod SD; Baregamian N
Front Endocrinol (Lausanne); 2023; 14():1223312. PubMed ID: 37492197
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of patient-derived salivary gland cancer organoid cultures.
Lassche G; van Boxtel W; Aalders TW; van Hooij O; van Engen-van Grunsven ACH; Verhaegh GW; van Herpen CML; Schalken JA
Oral Oncol; 2022 Dec; 135():106186. PubMed ID: 36265373
[TBL] [Abstract][Full Text] [Related]
32. Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy.
Gong M; Meng H; Tan D; Li P; Qin J; An Q; Shi C; An J
Animal Model Exp Med; 2023 Oct; 6(5):409-418. PubMed ID: 37890865
[TBL] [Abstract][Full Text] [Related]
33. Patient-Derived Organoids as Therapy Screening Platforms in Cancer Patients.
Khorsandi D; Yang JW; Foster S; Khosravi S; Hosseinzadeh Kouchehbaghi N; Zarei F; Lee YB; Runa F; Gangrade A; Voskanian L; Adnan D; Zhu Y; Wang Z; Jucaud V; Dokmeci MR; Shen X; Bishehsari F; Kelber JA; Khademhosseini A; de Barros NR
Adv Healthc Mater; 2024 Feb; ():e2302331. PubMed ID: 38359321
[TBL] [Abstract][Full Text] [Related]
34. Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives.
Chan WS; Mo X; Ip PPC; Tse KY
Cancer Med; 2023 Oct; 12(19):19714-19731. PubMed ID: 37776168
[TBL] [Abstract][Full Text] [Related]
35. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Saeki S; Kumegawa K; Takahashi Y; Yang L; Osako T; Yasen M; Otsuji K; Miyata K; Yamakawa K; Suzuka J; Sakimoto Y; Ozaki Y; Takano T; Sano T; Noda T; Ohno S; Yao R; Ueno T; Maruyama R
Breast Cancer Res; 2023 Feb; 25(1):21. PubMed ID: 36810117
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
[TBL] [Abstract][Full Text] [Related]
37. Ultrastructural analysis of breast cancer patient-derived organoids.
Signati L; Allevi R; Piccotti F; Albasini S; Villani L; Sevieri M; Bonizzi A; Corsi F; Mazzucchelli S
Cancer Cell Int; 2021 Aug; 21(1):423. PubMed ID: 34376194
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
39. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids.
Naumann M; Czempiel T; Lößner AJ; Pape K; Beyreuther E; Löck S; Drukewitz S; Hennig A; von Neubeck C; Klink B; Krause M; William D; Stange DE; Bütof R; Dietrich A
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954444
[TBL] [Abstract][Full Text] [Related]
40. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
Cioce M; Fumagalli MR; Donzelli S; Goeman F; Canu V; Rutigliano D; Orlandi G; Sacconi A; Pulito C; Palcau AC; Fanciulli M; Morrone A; Diodoro MG; Caricato M; Crescenzi A; Verri M; Fazio VM; Zapperi S; Levrero M; Strano S; Grazi GL; La Porta C; Blandino G
J Exp Clin Cancer Res; 2023 Jul; 42(1):170. PubMed ID: 37460938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
